MIRM
Mirum Pharmaceuticals, Inc.
Stock
$82.93−0.99 (−1.18%)Close Oct 2, 2026
- EBITDA, 2025
- $2.1M
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | $2.1M | — |
| 2024 | −$64M | — |
| 2023 | −$98M | — |
| 2022 | −$128M | — |
| 2021 | −$173M | — |
| 2020 | −$104M | — |
| 2019 | −$55M | — |
Mirum Pharmaceuticals, Inc.
$82.93−0.99 (−1.18%)Close Oct 2, 2026
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | $2.1M | — |
| 2024 | −$64M | — |
| 2023 | −$98M | — |
| 2022 | −$128M | — |
| 2021 | −$173M | — |
| 2020 | −$104M | — |
| 2019 | −$55M | — |